JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Search

Quidel Corp

Fermé

11.21 -5.88

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.83

Max

11.88

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+73.7% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-483M

726M

Ouverture précédente

17.09

Clôture précédente

11.21

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 avr. 2026, 00:00 UTC

Résultats

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 avr. 2026, 00:00 UTC

Résultats

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 avr. 2026, 23:47 UTC

Market Talk

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 avr. 2026, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 avr. 2026, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

23 avr. 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 avr. 2026, 23:13 UTC

Acquisitions, Fusions, Rachats

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 avr. 2026, 22:33 UTC

Résultats

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 avr. 2026, 22:17 UTC

Résultats

PLS Executed Offtake Agreement With Ronbay

23 avr. 2026, 22:17 UTC

Résultats

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 avr. 2026, 22:16 UTC

Résultats

PLS Commences Commissioning of Midstream Demonstration Plant

23 avr. 2026, 22:15 UTC

Résultats

PLS Group Reaffirms FY26 Guidance for All Metrics

23 avr. 2026, 22:14 UTC

Résultats

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 avr. 2026, 22:14 UTC

Résultats

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 avr. 2026, 22:13 UTC

Résultats

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 avr. 2026, 22:12 UTC

Résultats

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 avr. 2026, 22:12 UTC

Résultats

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 avr. 2026, 22:11 UTC

Résultats

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 avr. 2026, 22:10 UTC

Résultats

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 avr. 2026, 22:09 UTC

Résultats

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 avr. 2026, 22:08 UTC

Résultats

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 avr. 2026, 22:04 UTC

Résultats

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 avr. 2026, 21:56 UTC

Market Talk
Résultats

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 avr. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 avr. 2026, 21:27 UTC

Résultats

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 avr. 2026, 21:25 UTC

Résultats

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 avr. 2026, 21:24 UTC

Résultats

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 avr. 2026, 21:24 UTC

Résultats

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 avr. 2026, 21:21 UTC

Résultats

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 avr. 2026, 21:21 UTC

Résultats

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

73.7% hausse

Prévisions sur 12 Mois

Moyen 20.67 USD  73.7%

Haut 30 USD

Bas 15 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat